Induction of TRIM11 is a novel therapeutic choice to suppress Axin1 expression and orchestrate β-catenin activation, thus inhibiting the Wnt pathway-driven GC tumorigenesis and progression. The gene discussed is TRIM11; the disease is gastric cancer.